首页> 外文期刊>Platelets >Decreased turnover aspirin resistance by bidaily aspirin intake and efficient cytoreduction in myeloproliferative neoplasms
【24h】

Decreased turnover aspirin resistance by bidaily aspirin intake and efficient cytoreduction in myeloproliferative neoplasms

机译:通过Bidaily Aspirin进气和高效细胞渗透培养的胞质瘤瘤中的营养素抵抗力减少

获取原文
获取原文并翻译 | 示例
           

摘要

Essential thrombocythemia (ET) and polycythemia vera (PV) are myeloproliferative neoplasms (MPN) with an increased risk of arterial and venous thrombosis. Aspirin is recommended to reduce this risk, but resistance to antiplatelet therapy seems to hamper its efficacy in some patients. We have previously shown that multiple electrode aggregometry (MEA) was a valuable tool to assess aspirin resistance in MPN. In this study, MEA was used to assess the reduction in aspirin resistance after bi-daily (BID) aspirin intake or cytoreduction.
机译:原发性血小板增多症(ET)和真性红细胞增多症(PV)是骨髓增生性肿瘤(MPN),动脉和静脉血栓形成的风险增加。建议使用阿司匹林来降低这种风险,但抗血小板治疗的耐药性似乎会阻碍其在某些患者中的疗效。我们之前已经证明,多电极聚集测定法(MEA)是评估MPN患者阿司匹林抵抗的一种有价值的工具。在这项研究中,MEA用于评估每日两次(BID)服用阿司匹林或细胞减少后阿司匹林抵抗的降低。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号